Dallas Voice (Dallas, Tex.), Vol. 37, No. 5, Ed. 1 Friday, June 5, 2020 Page: 3 of 40
forty pages : ill.View a full description of this newspaper.
Extracted Text
The following text was automatically extracted from the image on this page using optical character recognition software:
»A.
3aj
L
A
45
1
4
3 3’
W;
4
Because HIV doesn’t change who you are.
Featured patient compensated by Gilead.
4 GILEAD
BIKTARVY® is a complete, 1-pill, once-a-day prescription medicine used
to treat HIV-1 in certain adults. BIKTARVY does not cure HIV-1 or AIDS.
DIMITRI A4
LIVING WITH HIV SINCE 2018
REAL BIKTARVY PATIENT
Please see Important Facts about BIKTARVY, including important
warnings, on the previous page and visit BIKTARVY.com.
Ask your healthcare provider if BIKTARVY is right for you.
See Dimitri’s story at BIKTARVY.com.
LOVE
WHAT’S
INSIDE8
P
BIKTARVY8
bictegravir 50mg/emtricitabine 200mg/
tenofovir alafenamide 25mg tablets
p
Upcoming Pages
Here’s what’s next.
Search Inside
This issue can be searched. Note: Results may vary based on the legibility of text within the document.
Tools / Downloads
Get a copy of this page or view the extracted text.
Citing and Sharing
Basic information for referencing this web page. We also provide extended guidance on usage rights, references, copying or embedding.
Reference the current page of this Newspaper.
Nash, Tammye. Dallas Voice (Dallas, Tex.), Vol. 37, No. 5, Ed. 1 Friday, June 5, 2020, newspaper, June 5, 2020; Dallas, Texas. (https://texashistory.unt.edu/ark:/67531/metapth1460981/m1/3/: accessed July 18, 2024), University of North Texas Libraries, The Portal to Texas History, https://texashistory.unt.edu; crediting UNT Libraries Special Collections.